Navigating Acinetobacter baumannii Resistance

This chapter explores the challenges of treating carbapenem-resistant Acinetobacter baumannii (CRAB) infections, addressing high mortality rates and the complexities of distinguishing between colonization and infection. It also highlights innovative treatment options, including the Sulbactam-Durlobactam combination, and the operational hurdles faced in clinical settings. Furthermore, the discussion underscores the need for continued research and surveillance to combat the evolving resistance mechanisms of this pathogen.